129 Cabazitaxel for metastatic castration resistant...

129 Cabazitaxel for metastatic castration resistant prostate cancer (mCRPC): Interim safety and quality of life (QOL) data from the UK early access programme

A.K. Bahl, S. Masson, Z. Malik, A. Birtle, S. Sundar, R. Jones, N. James, M. Mason, S. Kumar, D. Bottomley, A. Lydon, S. Chowdhury, J. Wylie, J. De Bono
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
11
Year:
2012
Language:
english
DOI:
10.1016/s1569-9056(12)60128-6
File:
PDF, 20 KB
english, 2012
Conversion to is in progress
Conversion to is failed